The estimated Net Worth of Sheryl L Conley is at least $279 Tausend dollars as of 1 June 2021. Ms. Conley owns over 6,200 units of Neuronetics Inc stock worth over $29,357 and over the last 5 years she sold STIM stock worth over $180,690. In addition, she makes $69,085 as Independent Director at Neuronetics Inc.
Sign up
Ms. Conley STIM stock SEC Form 4 insiders trading
Sheryl has made over 2 trades of the Neuronetics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 6,200 units of STIM stock worth $86,986 on 1 June 2021.
The largest trade she's ever made was selling 6,800 units of Neuronetics Inc stock on 27 May 2021 worth over $93,704. On average, Sheryl trades about 1,083 units every 0 days since 2019. As of 1 June 2021 she still owns at least 39,672 units of Neuronetics Inc stock.
You can see the complete history of Ms. Conley stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sheryl Conley biography
Sheryl L. Conley serves as Independent Director of the Company. Ms. Conley is a 30-year veteran of the orthopedic medical device industry with expertise and executive leadership experience in running full P&L business segments, global brand management, marketing, sales, product development, and operations. Since March 2017, Ms. Conley has been President and Board Member of AcceLINX, Inc., a musculoskeletal health business accelerator, Board Director of Orthopedics Capital Foundation, an active angel investor and has been a board participant for private and non-profit entities. From September 2012 to May 2017, Ms. Conley was President and CEO of OrthoWorx, Inc., a community-based initiative that works strategically and collaboratively with the orthopedic industry and other stakeholders to ensure that the Warsaw region continues to reap the social and economic benefits that derive from its position as The Orthopedic Capital of the World.™ Prior to her role as the President and CEO of OrthoWorx, Ms. Conley spent 25 years with Zimmer, Inc. in a number of escalating management roles across a variety of product segments and geographies, during which she provided key leadership in the development and commercial release of over 50 industry leading brands, including as Group President, Americas and Global Brand Management, and Chief Marketing Officer from December 2005 until May 2008. Ms. Conley holds a Bachelor of Science (Biology and Chemistry) and an MBA from Ball State University (IN).
What is the salary of Sheryl Conley?
As the Independent Director of Neuronetics Inc, the total compensation of Sheryl Conley at Neuronetics Inc is $69,085. There are 10 executives at Neuronetics Inc getting paid more, with Daniel Guthrie having the highest compensation of $1,937,180.
How old is Sheryl Conley?
Sheryl Conley is 58, she's been the Independent Director of Neuronetics Inc since 2019. There are 7 older and 6 younger executives at Neuronetics Inc. The oldest executive at Neuronetics Inc is Wilfred Jaeger, 64, who is the Independent Director.
Insiders trading at Neuronetics Inc
Over the last 6 years, insiders at Neuronetics Inc have traded over $9,582,393 worth of Neuronetics Inc stock and bought 1,499,267 units worth $4,708,316 . The most active insiders traders include Capital Llc Cannell, Ronald Hunt und Glenn P Muir. On average, Neuronetics Inc executives and independent directors trade stock every 20 days with the average trade being worth of $21,199. The most recent stock trade was executed by Glenn P Muir on 5 September 2024, trading 25,000 units of STIM stock currently worth $20,000.
What does Neuronetics Inc do?
with neurostar advanced therapy, neuronetics, inc., is the market leader in transcranial magnetic stimulation technology for the treatment of major depressive disorder. based in malvern, pa, we are a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using mri-strength magnetic field pulses. we are the first company to have a non-systemic and non-invasive depression treatment cleared by the fda for patients who have not benefited from prior antidepressant medication. neuronetics markets neurostar advanced therapy throughout the united states and select markets around the world. if you have questions or comments about neurostar, please e-mail us at customersupport@neuronetics.com. for u.s. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207.
What does Neuronetics Inc's logo look like?
Complete history of Ms. Conley stock trades at Anika Therapeutics und Neuronetics Inc
Neuronetics Inc executives and stock owners
Neuronetics Inc executives and other stock owners filed with the SEC include:
-
Daniel Guthrie,
Chief Commercial Officer -
Stephen Furlong,
Vice President, Chief Financial Officer, Office of the President -
Gregory Harper,
Vice President - Product Development and Operations -
Keith J. Sullivan,
Pres, CEO & Director -
Yelena Tropsha,
Vice President - Commercial Access -
Stephen J. Furlong M.S.,
Sr. VP, CFO & Treasurer -
W. Andrew Macan,
Sr. VP, Gen. Counsel, Chief Compliance Officer, Sec. & Member of Office of the Pres -
Brian Farley,
Independent Non-Executive Chairman of the Board -
Glenn Muir,
Independent Director -
Wilfred Jaeger,
Independent Director -
Sheryl Conley,
Independent Director -
Mark Klausner,
Managing Partner -
Bruce Shook,
Independent Director -
John Bakewell,
Director -
Sara Grubbs,
Vice President of Sales -
W. Andrew Macan,
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary, Office of the President -
Keith Sullivan,
President, Chief Executive Officer, Director -
Kara Thornton,
VP of HR & Sr. Director -
Claire Sears,
VP of Marketing -
Leaf Ventures Ii, L.P.New L...,
-
Paulina Hill,
Director -
Stephen M Campe,
Director -
Ventures Ltd General Electr...,
-
Ronald Hunt,
Director -
Growth Capital, Llc Investor,
10% owner -
Megan Rosengarten,
-
Christopher Thatcher,
President and CEO -
Peter Donato,
Vice President and CFO -
Cheryl R Blanchard,
Director -
Capital Llc Cannell,
10% owner -
Joseph H Capper,
Director -
Robert Cascella,